Adcock Ingram Holdings Limited (JSE:AIP) — Market Cap & Net Worth
Market Cap & Net Worth: Adcock Ingram Holdings Limited (AIP)
Adcock Ingram Holdings Limited (JSE:AIP) has a market capitalization of $583.42 Million (ZAC1.10 Trillion) as of September 24, 2026. Listed on the JSE stock exchange, this South Africa-based company holds position #11622 globally and #86 in its home market, demonstrating a 0.19% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Adcock Ingram Holdings Limited's stock price ZAC7480.00 by its total outstanding shares 146762866 (146.76 Million). Also see Adcock Ingram Holdings Limited balance sheet assets for a full breakdown of the balance sheet.
Adcock Ingram Holdings Limited Market Cap History: 2015 to 2025
Adcock Ingram Holdings Limited's market capitalization history from 2015 to 2025. Data shows growth from $307.96 Million to $583.42 Million (5.75% CAGR). Also see Adcock Ingram Holdings Limited operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Adcock Ingram Holdings Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Adcock Ingram Holdings Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check current stock price of Adcock Ingram Holdings Limited for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.06x
Adcock Ingram Holdings Limited's market cap is 0.06 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.68x
Adcock Ingram Holdings Limited's market cap is 0.68 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $304.35 Million | $5.55 Billion | $168.80 Million | 0.05x | 1.80x |
| 2017 | $376.14 Million | $5.94 Billion | $553.53 Million | 0.06x | 0.68x |
| 2018 | $413.65 Million | $6.54 Billion | $637.94 Million | 0.06x | 0.65x |
| 2019 | $368.47 Million | $7.08 Billion | $687.99 Million | 0.05x | 0.54x |
| 2020 | $323.12 Million | $7.35 Billion | $676.37 Million | 0.04x | 0.48x |
| 2021 | $367.84 Million | $7.78 Billion | $657.46 Million | 0.05x | 0.56x |
| 2022 | $384.42 Million | $8.71 Billion | $800.35 Million | 0.04x | 0.48x |
| 2023 | $468.76 Million | $9.13 Billion | $898.41 Million | 0.05x | 0.52x |
| 2024 | $522.58 Million | $9.64 Billion | $814.01 Million | 0.05x | 0.64x |
| 2025 | $583.42 Million | $9.76 Billion | $858.51 Million | 0.06x | 0.68x |
Competitor Companies of AIP by Market Capitalization
Companies near Adcock Ingram Holdings Limited in the global market cap rankings as of September 24, 2026. Review AIP intangible-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Adcock Ingram Holdings Limited by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #524 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #586 globally with a market cap of $46.44 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #638 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #651 globally with a market cap of $42.68 Billion USD ( CN¥291.65 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #524 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #586 | GALDERMA GROUP AG | NYSE:GALDY | $46.44 Billion | $39.83 |
| #638 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.50 |
| #651 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $42.68 Billion | CN¥45.72 |
Adcock Ingram Holdings Limited Historical Marketcap From 2015 to 2025
Between 2015 and today, Adcock Ingram Holdings Limited's market cap moved from $307.96 Million to $ 583.42 Million, with a yearly change of 5.75%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | ZAC583.42 Million | +11.64% |
| 2024 | ZAC522.58 Million | +11.48% |
| 2023 | ZAC468.76 Million | +21.94% |
| 2022 | ZAC384.42 Million | +4.51% |
| 2021 | ZAC367.84 Million | +13.84% |
| 2020 | ZAC323.12 Million | -12.31% |
| 2019 | ZAC368.47 Million | -10.92% |
| 2018 | ZAC413.65 Million | +9.97% |
| 2017 | ZAC376.14 Million | +23.59% |
| 2016 | ZAC304.35 Million | -1.17% |
| 2015 | ZAC307.96 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 23rd, 2026 the market cap of Adcock Ingram Holdings Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $583.42 Million USD |
| MoneyControl | $583.42 Million USD |
| MarketWatch | $583.42 Million USD |
| marketcap.company | $583.42 Million USD |
| Reuters | $583.42 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Adcock Ingram Holdings Limited
Adcock Ingram Holdings Limited, together with its subsidiaries, engages in the manufacture, marketing, and distribution of healthcare products to private and public sectors in Southern Africa and India. It operates through four segments: Consumer, Over the Counter (OTC), Prescription, and Hospital Products and Services. The company provides various healthcare, personal care, and homecare products… Read more